Core Viewpoint - The company has decided to terminate the raw material drug project due to uncertainties in the project's second phase and aims to find more profitable projects for the remaining raised funds [2][8][10]. Fundraising Overview - The company raised a total of RMB 1,995.79 million by issuing 17.55 million shares at RMB 113.72 per share [2][3]. - As of June 30, 2025, the cumulative investment in the raw material drug project was RMB 178.70 million, with pending payments of RMB 6.11 million and remaining funds of RMB 215.69 million [2][6]. Investment Projects - The company has several fundraising investment projects, including: - OLED and other functional materials production project with a total investment of RMB 300.00 million [4]. - High-end liquid crystal display materials production project with a total investment of RMB 310.00 million [4]. - Resource harmless treatment project with a total investment of RMB 37.21 million [4]. - Research and testing center project with an investment of RMB 170.00 million [4]. - Working capital supplement of RMB 260.00 million [4]. Termination of Investment Project - The raw material drug project was intended to expand the company's pharmaceutical CDMO business, with a total investment of RMB 423.00 million, using RMB 369.00 million of excess raised funds [6][8]. - The first phase of the project has been completed, but the second phase has not started due to uncertainties in product planning and regulatory approval processes [7][8]. Impact of Termination - The decision to terminate the raw material drug project is based on current industry trends and aims to optimize the use of resources and funds, ensuring high-quality project implementation [8][10]. - The termination is not expected to adversely affect the company's normal operations and aligns with its long-term development strategy [8][10]. Review Procedures - The board and supervisory committee approved the termination of the investment project, which will be submitted for shareholder approval [10][11]. - The supervisory committee and the sponsor institution have expressed their agreement with the decision, confirming that it complies with relevant regulations and does not harm shareholder interests [10][11].

杭州华星创业通信技术股份有限公司 第一章 总 则 第一条 为规范公司募集资金管理，提高募集资金使用效率，根据《中华人 民共和国公司法》、《中华人民共和国证券法》、《上市公司证券发行注册管理 办法》、《上市公司募集资金监管规则》、《深圳证券交易所创业板股票上市规 则》、《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范 运作》等相关法律、法规和规范性文件和《杭州华星创业通信技术股份有限公司 章程》(以下简称"《公司章程》")的规定，制定本制度。 第二条 公司募集资金管理适用本制度。 第三条 本制度所称募集资金是指公司通过发行股票及其衍生品种，向投 资者募集并用于特定用途的资金，但不包括公司实施股权激励计划募集的资金。 第四条 公司董事会负责健全并确保本制度的有效实施。 募集资金投资项目通过公司的子公司或公司控制的其他企业实施的，公司确 保该子公司或公司控制的其他企业遵守本制度。 第五条 保荐机构及其保荐代表人在持续督导期间对本制度规定的事项履 行保荐职责，对公司募集资金管理的持续督导工作。 第二章 募集资金专户存储 第六条 公司应当在商业银行开设募集资金专项账户（以下简称"专户"）， 该专户不 ...

Core Points - The company has established a fundraising management system to regulate the use and management of raised funds, ensuring the protection of investors' rights [1] - The system applies to the storage, use, change, supervision, and accountability of raised funds [1] - The company must accept the responsibilities of sponsors in accordance with relevant regulations and this system [1] Fund Storage - The company must prudently select commercial banks and open special accounts for fundraising, ensuring that funds are stored in approved accounts [2] - A tripartite supervision agreement must be signed within one month of the funds being received, detailing the management of the special account [2][3] - If the commercial bank fails to provide timely statements, the company can terminate the agreement and close the account [3] Fund Usage - The company must strictly follow approval procedures for fund expenditures, ensuring that all spending aligns with the planned use of funds [4] - Funds must primarily be used for the company's main business, and cannot be used for financial investments or to benefit related parties [5] - Any surplus funds from completed projects must be approved by the board before being redirected to other projects [11] Changes in Fund Direction - Any changes to fundraising projects must be approved by the board and disclosed to the stock exchange [19] - The company must conduct feasibility analyses for new projects and ensure they align with the main business [20] - Surplus funds can only be used for other projects after board approval and must be disclosed [11][12] Supervision and Reporting - The company must conduct semi-annual reviews of fundraising projects and disclose the findings in a special report [28] - Independent auditors must verify the management and usage of funds annually, with results disclosed in the annual report [28][29] - The board must report any violations of the fundraising management system to the stock exchange [17]

Summary of Key Points Core Viewpoint - The company has decided to terminate certain fundraising projects and adjust the implementation locations of others to optimize resource allocation and improve fundraising efficiency [5][9]. Fundraising Overview - The company raised a total of RMB 1,172.4 million through its initial public offering, with a net amount of RMB 1,057.89 million after deducting issuance costs [1][2]. - The fundraising plan included a total investment of RMB 839.74 million across various projects [2]. Changes in Fundraising Projects - The company has approved the addition of a new project, "Solar Photovoltaic Module Junction Box Production Project," and adjusted the investment amounts for existing projects [2][3]. - The total investment for the revised fundraising plan is RMB 1,319.74 million, with the planned fundraising amount remaining at RMB 839.74 million [3]. Termination of Fundraising Projects - The "Annual Production of 6.5 Million Sets of New Energy Vehicle Roofs, Mudguards, and Wiring Harnesses Construction Project" has been terminated due to internal business integration needs [5]. - The total investment for the terminated project was RMB 100 million, with RMB 88 million planned for fundraising, of which RMB 23.77 million has been utilized [5][6]. Reasons for Project Termination - The decision to terminate the project was based on the assessment that existing production capacity meets current demand, and further investment could lead to idle capacity risks [5]. - The company aims to enhance fundraising efficiency and avoid redundant construction by reallocating resources to higher-priority projects [5]. Use of Remaining Funds - Remaining funds from the terminated project will continue to be stored in a dedicated account, with plans for future investment in projects that demonstrate good market prospects [6]. - The company will ensure compliance with relevant regulations regarding the use of fundraising [6]. New Implementation Locations - The company has proposed a new implementation location for the "R&D Center Upgrade Project" to optimize resource allocation and accelerate project progress [7]. - The new location is expected to enhance the quality of fundraising projects and improve overall competitiveness [7]. Review Procedures and Opinions - The board of directors has approved the termination and location changes, stating that these decisions will not adversely affect the company's operations and align with long-term development goals [8][9]. - The sponsor institution has confirmed that the changes comply with relevant regulations and do not harm shareholder interests [9].

Fundraising Overview - China National Nuclear Power Co., Ltd. has successfully raised a total of approximately RMB 13.99 billion by issuing 1,684,717,207 A-shares at a price of RMB 8.31 per share, after deducting issuance costs of RMB 2.35 million, resulting in a net amount of RMB 13.99 billion [1][2] - The raised funds have been deposited into a designated fundraising account, and a tripartite supervision agreement has been signed with the underwriter and the commercial banks involved [2][3] Fund Management and Supervision - The company has established special accounts for fundraising at China Construction Bank, Industrial and Commercial Bank of China, and Bank of China, with the aim of ensuring proper management and usage of the funds [2][3] - A four-party supervision agreement has been signed, which includes the company, its subsidiaries, the banks, and the underwriter, to ensure that the funds are not used for non-designated purposes [2][3] Compliance and Reporting - The agreement stipulates that the funds can only be used for the intended projects and must be reported to the underwriter monthly regarding the status of the funds and any cash management products [3][4] - The underwriter has the right to conduct on-site investigations and audits to ensure compliance with the agreement and proper usage of the funds [4][5]

第二条 本制度所称募集资金系指公司通过发行股票或者其他具有股权性质 的证券，向投资者募集并用于特定用途的资金，但不包括公司实施股权激励计划 募集的资金监管。 第三条 公司募集资金应当专款专用。公司使用募集资金应当符合国家产业 政策和相关法律法规，践行可持续发展理念，履行社会责任，原则上应当用于主 营业务，有利于增强公司竞争能力和创新能力。除金融类企业外，募集资金不得 用于持有财务性投资，不得直接或者间接投资于以买卖有价证券为主要业务的公 司。 第四条 公司应当审慎使用募集资金，保证募集资金的使用与发行申请文件 的承诺相一致，不得随意改变募集资金的投向。 公司应当真实、准确、完整地披露募集资金的实际使用情况。出现严重影响 募集资金投资计划正常进行的情形时，应当及时公告。 募集资金投资项目通过公司的子公司或者公司控制的其他企业实施的，公司 应当确保该子公司或者受控制的其他企业遵守本制度。 第五条 公司董事会建立并完善募集资金存放、管理、使用、改变用途、监 督和责任追究的内部控制制度，明确募集资金使用的分级审批权限、决策程序、 风险控制措施及信息披露要求，规范使用募集资金。 公司董事会应当持续关注募集资金存放、管理 ...

厦门延江新材料股份有限公司 募集资金使用管理办法 第一章 总 则 第一条 为加强和规范公司募集资金的管理和使用、切实保护投资者利益、 提高资金使用效率和效益，根据《中华人民共和国公司法》、 《中华人民共和国证 券法》、《上市公司募集资金监管规则》、《深圳证券交易所创业板股票上市规则》 （以下简称"《股票上市规则》"）、《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等法律、法规、规范性文件及《厦门延江新材 料股份有限公司章程》 （以下简称"公司章程"）的有关规定，结合公司的实际情 况，特制定本办法。 第二条 本办法适用于公司通过发行股票或者其他具有股权性质的证券，向 投资者募集并用于特定用途的资金监管，但不包括公司为实施股权激励计划募集 的资金监管。 公司以发行证券作为支付方式向特定对象购买资产的，按照本办法第五章的 有关规定执行。 第三条 募集资金投资项目（以下简称"募投项目"）通过公司的子公司或 公司控制的其他企业实施的，适用本办法的规定。 第四条 募集资金到位后，公司应及时办理验资手续，由具有证券从业资格 的会计师事务所出具验资报告。 第五条 公司募集资金应当专款专用。公司使用 ...

深圳市燕麦科技股份有限公司 募集资金管理制度 国证券法》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公 司自律监管指引第1号——规范运作》等相关法律、法规以及公司章程的规定，结合 公司实际情况，特制订本制度。 第二条 本制度适用于公司通过发行股票或者其他具有股权性质的证券，向投 资者募集并用于特定用途的资金监管，但不包括上市公司为实施股权激励计划募集 的资金监管。 第三条 本制度是公司对募集资金使用和管理的基本行为准则。如募集资金投 资项目（以下简称"募投项目"）通过公司的子公司或公司控制的其他企业实施的， 公司应当确保该子公司或控制的其他企业遵守本制度。 第四条 公司应当真实、准确、完整地披露募集资金的实际使用情况。公司出 现严重影响募集资金投资计划正常进行的情形时，应当及时公告。 第五条 公司董事会应当对募投项目的可行性进行充分论证，确信投资项目具 有较好的市场前景和盈利能力，有效防范投资风险，提高募集资金使用效益。 第六条 公司募集资金应当专款专用。公司使用募集资金应当符合国家产业政 策和相关法律法规，践行可持续发展理念，履行社会责任，原则上应当用于主营业 务，有利于增强公司竞争能力和 ...

Group 1 - The company completed the cancellation of its fundraising special account as the investment projects "Supercapacitor Industrialization Project" and "High Voltage Large Capacity Film Capacitor Project" have reached the predetermined usable status and met the completion conditions [2] - The total amount raised through the non-public offering was approximately 1.2 billion yuan, with a net amount of about 1.18 billion yuan after deducting issuance costs [1] - The company has established a special account for the management and storage of the raised funds, in compliance with relevant regulations and agreements [1][2] Group 2 - The board of directors approved the conclusion of the fundraising projects and the permanent allocation of surplus funds to supplement working capital for daily operations and business development [2] - The company has completed the payment of pending amounts related to the fundraising projects, totaling 50.48 million yuan, and transferred all surplus funds and interest out of the special account [2] - The company has notified the sponsor and representative of the cancellation of the fundraising special account, leading to the termination of the corresponding tripartite supervision agreement [2]

Core Viewpoint - Dongpeng Beverage Group Co., Ltd. has provided a detailed report on the management and usage of raised funds as of June 30, 2025, highlighting the total amount raised, the amount utilized, and the remaining balance in special accounts for the raised funds [1][2]. Summary by Sections 1. Basic Information on Raised Funds - The company raised a total of RMB 1,851.26 million by issuing 40,010,000 shares at RMB 46.27 per share in May 2021 [1]. - As of June 30, 2025, the total amount utilized from the raised funds is RMB 1,658.08 million, with RMB 24.93 million used in the first half of 2025, leaving a remaining balance of RMB 73.85 million [1][2]. 2. Management and Storage of Raised Funds - The company has established a management method for the raised funds to ensure compliance with regulatory requirements and protect investor interests [1]. - Special agreements have been signed with banks and sponsors to clarify the rights and obligations of all parties involved in the management of the raised funds [1]. 3. Usage of Raised Funds - The report details the specific projects funded by the raised capital, including construction projects and marketing initiatives, with a total of RMB 173.19 million allocated across various projects [3][4]. - The company has completed the use of funds for several projects, with the remaining funds primarily in cash management products [3][4]. 4. Changes in Fund Usage - The implementation subject of the R&D center construction project has been changed from a subsidiary in South China to another subsidiary in Zengcheng, without altering the total investment amount or project content [4][5]. - The company has approved the extension of the completion date for the headquarters building project to June 2026 due to strategic investment considerations [4][5]. 5. Compliance and Disclosure - The company confirms that all disclosures related to the usage of raised funds are timely, truthful, accurate, and complete, with no violations in the management and disclosure of raised funds [3][4].